Scientists identify potential vaccine candidate for pediatric malaria

May 22, 2014
Electron micrograph of a Plasmodium falciparum schizont-infected red blood cell. Credit: J. Kurtis

Researchers have identified a substance, or antigen, that generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection.

The antigen, known as PfSEA-1, was associated with reduced parasite levels among children and adults in -endemic areas. Mice exposed to PfSEA-1 in an investigational vaccine also experienced lower malaria parasite levels. The discovery of PfSEA-1 could be a critical addition to the limited pool of antigens currently used in candidate malaria vaccines. The findings, which appear in the May 23 issue of Science, result from a collaboration of scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and NIAID grantees.

An estimated 627,000 people die from malaria each year according to the World Health Organization, with most deaths from the mosquito-borne parasitic disease occurring among young children living in sub-Saharan Africa. People who live in areas where malaria is common frequently develop protective immune system responses that can limit levels in the blood and prevent the high fever and illness associated with .

Using from 2-year-old Tanzanian children who were either resistant or susceptible to malaria infection, researchers performed gene-screening experiments and a series of laboratory tests that identified PfSEA-1. Multiple tests confirmed that antibodies to PfSEA-1 halted malaria infection at the point when the parasite leaves one red blood cell to invade a new one. This stage offers a unique target for future malaria vaccines as previous vaccine candidates have tried to block the stage when parasites enter red blood cells, according to the authors.

The video will load shortly
Jonathan Kurtis, M.D., Ph.D., director of the Center for International Health Research at Rhode Island Hospital, talks about the latest findings in their research to find a vaccine for malaria, which kills one child every 15 seconds in Sub-Saharan Africa and Southeast Asia. Credit: LIFESPAN

Scientists then vaccinated five groups of mice with the novel antigen to evaluate its effects after the mice were exposed to malaria. In all groups, the vaccinated mice had lower levels of malaria parasites and survived longer than the unvaccinated mice. Additionally, the researchers measured antibody levels in plasma samples from 453 Tanzanian children from the previous cohort and discovered that no cases of occurred during periods when the children had detectable antibodies to PfSEA-1.

Further, the scientists evaluated plasma samples from 138 males ages 12-35 years living in a malaria-endemic area of Kenya and found that individuals with detectable antibodies to PfSEA-1 had 50 percent lower parasite densities compared to individuals with no detectable antibodies. Together, these findings support PfSEA-1 as a potential vaccine candidate that could work alone or together with other vaccines targeting different stages of malaria infection, the authors write.

Explore further: Malaria severity not determined solely by parasite levels in blood

More information: DK Raj et al. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science DOI: 10.1126/science.1254417 (2014). DOI: 10.1126/science.1254417

Related Stories

Recommended for you

The tale of the bats, dark matter and a plastic surgeon

October 25, 2016

What happens when a plastic surgeon meets a bat expert zoologist and a paleobiologist? No, it's not a strange Halloween story about spooky bat dinosaurs but rather, a story about a new discovery about bats which may unlock ...

Study links small RNA molecule to pregnancy complication

October 24, 2016

A family of small RNA molecules affects the development of cells that give rise to the placenta - an organ that transfers oxygen and nutrients from mother to fetus—in ways that could contribute to a serious pregnancy complication, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.